D
Donald Garmon
Researcher at Aaron Diamond AIDS Research Center
Publications - 5
Citations - 326
Donald Garmon is an academic researcher from Aaron Diamond AIDS Research Center. The author has contributed to research in topics: Cart & Cohort. The author has an hindex of 5, co-authored 5 publications receiving 297 citations. Previous affiliations of Donald Garmon include National Institutes of Health & University of Sydney.
Papers
More filters
Journal ArticleDOI
Evidence of dysregulation of dendritic cells in primary HIV infection.
Rachel Lubong Sabado,Rachel Lubong Sabado,Meagan O’Brien,Meagan O’Brien,Abhignya Subedi,Abhignya Subedi,Li Qin,Li Qin,Nan Hu,Nan Hu,Elizabeth Taylor,Elizabeth Taylor,Oliver Dibben,Oliver Dibben,Andrea Stacey,Andrea Stacey,Jacques Fellay,Jacques Fellay,Kevin V. Shianna,Kevin V. Shianna,Frederick P. Siegal,Michael Shodell,Kokila Shah,Marie Larsson,Jeffrey D. Lifson,Arthur Nádas,Michael Marmor,Richard Hutt,David M. Margolis,David M. Margolis,Donald Garmon,Donald Garmon,Martin Markowitz,Martin Markowitz,Fred T. Valentine,Persephone Borrow,Persephone Borrow,Nina Bhardwaj,Nina Bhardwaj +38 more
TL;DR: It is found that both myeloid DC and plasmacytoid DC levels decline very early during acute HIV infection, which implicates a possible role for DCs in promoting chronic immune activation.
Journal ArticleDOI
A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals.
Martin Markowitz,Teresa H. Evering,Donald Garmon,Marina Caskey,Melissa La Mar,Kristina Rodriguez,Vincent Sahi,Sarah Palmer,Nicole Prada,Hiroshi Mohri +9 more
TL;DR: Intensified 5-drug cART initiated during early infection fails to significantly further impact virologic or immunologic responses beyond those achieved with standard 3-drug PI-based cART.
Journal ArticleDOI
Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City.
Delivette Castor,Andrea Low,Teresa H. Evering,Sharon L. Karmon,Brandi Davis,Amir Figueroa,Melissa LaMar,Donald Garmon,Saurabh Mehandru,Martin Markowitz +9 more
TL;DR: Transmitted drug resistance is stable in this cohort and remains a significant concern to both individual patient management and the public health.
Journal ArticleDOI
Behavioural, Mucosal and Systemic Immune Parameters in HIV-infected and Uninfected Injection Drug Users.
Saurabh Mehandru,Sherry Deren,Sung-Yeon Kang,Angela Banfield,Aakash Garg,Donald Garmon,Melissa LaMar,Teresa H. Evering,Martin Markowitz +8 more
TL;DR: Pilot results provide compelling preliminary results which in turn support larger studies to better define the relationship between IDU, infection with HIV-1, co-infection with Hepatitis C and immunity.
Journal ArticleDOI
Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection.
Teresa H. Evering,Allison J. Applebaum,Melissa La Mar,Donald Garmon,David M. Dorfman,Martin Markowitz +5 more
TL;DR: Rates of HAND in this cohort of HIV-infected men without comorbid conditions who initiated early cART are low and the findings suggest a possible neuroprotective benefit of early c ART and an important contribution ofComorbidities to observed HAND prevalence.